Summary
Updated Aug 30, 2026
Pierre Legault files SEC Form 4 reports at Syndax Pharmaceuticals Inc (SNDX). 1 SEC Form 4 filing on record, dated 6 February 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Pierre Legault has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Pierre Legault files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael A. Metzger - $4.01M of SNDX open-market activity in the last 12 months
- Nicholas A.J. Botwood - $1.18M of SNDX open-market activity in the last 12 months
- Keith A. Goldan - $137K of SNDX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Pierre Legault?
Pierre Legault is a corporate insider of Syndax Pharmaceuticals Inc (SNDX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Pierre Legault last file a Form 4?
The only primary Form 4 on record is dated 6 February 2026.
Where can I see all of Pierre Legault's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Pierre Legault and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
